Bill Status of HB5327

  1. Home
  2. Legislation
  3. Bill Status

HB5327 - 104th General Assembly

PRESCRIPTION LABELING
Last Action
2/10/2026 - House: Referred to Rules Committee
Statutes Amended In Order of Appearance
225 ILCS 60/33from Ch. 111, par. 4400-33
225 ILCS 85/22from Ch. 111, par. 4142
Synopsis As Introduced
Amends the Medical Practice Act of 1987. In provisions concerning legend drugs, provides that, at the request of a person dispensing a drug or medicine, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the dispensing health care practice instead of the name of the person dispensing the drug or medicine. Amends the Pharmacy Practice Act. In provisions concerning the label of a drug, medicine, or poison that is lawfully sold or dispensed, provides that, at a prescriber's request, the label affixed to a box, bottle, vessel, or package containing mifepristone, misoprostol, or any generic alternative may include the name of the prescribing health care practice instead of the name of the prescriber.
Actions
Date Chamber Action
2/05/2026 House Filed with the Clerk by Rep. Mary Beth Canty
2/10/2026 House First Reading
2/10/2026 House Referred to Rules Committee
2/18/2026 House Added Co-Sponsor Rep. Daniel Didech
2/18/2026 House Added Co-Sponsor Rep. Will Guzzardi
3/06/2026 House Added Co-Sponsor Rep. Joyce Mason
3/10/2026 House Added Co-Sponsor Rep. Justin Cochran